“ The combined radiographic response and symptomatic improvement observed in this patient and the strong correlation with histological data demonstrated the investigational therapy’s intended cellular ...

A rebound of COVID-19 symptoms in some patients after taking Pfizer's antiviral Paxlovid may be related to a robust immune response rather than a weak one, U.S. government researchers reported on ...

Using data from the Human Cell Atlas, researchers have identified the differences in immune cells' response in those who had no symptoms compared to severe symptoms. The largest study of its type in ...